Company
Headquarters: Yokohama, Japan
Employees: 303
CEO: Mr. Toshiyuki Shuto
¥28.84 Billion
JPY as of Jan. 1, 2024
US$204.8 Million
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells APIs/intermediates in Japan. It is also involved in the manufacture and marketing of various injections; OTC drugs, primarily various vitamins; and manufacture and sale of generic drugs. In addition, the company engages in contract manufacturing of pharmaceuticals; and packaging of pharmaceutical products. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Koa Shoji Holdings Co.,Ltd. has the following listings and related stock indices.
Stock: JPX: 9273 wb_incandescent